Silencing of latent membrane protein 2B reduces susceptibility to activation of lytic Epstein-Barr virus in Burkitt's lymphoma Akata cells

Journal of General Virology

Volumn 88, Issue 5, 2007, Pages 1454-1459

  Rechsteiner, Markus P ^a   Berger, Christoph ^a   Weber, Matthias ^a   Sigrist, Jürg A ^a   Nadal, David ^a   Bernasconi, Michele ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; IMMEDIATE EARLY PROTEIN BZLF1; LATENT MEMBRANE PROTEIN 2; LATENT MEMBRANE PROTEIN 2A; LATENT MEMBRANE PROTEIN 2B; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; BURKITT LYMPHOMA; CELL ACTIVATION; CROSS LINKING; EPSTEIN BARR VIRUS; GENE OVEREXPRESSION; GENE SILENCING; GENETIC SUSCEPTIBILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VIRUS REACTIVATION; VIRUS REPLICATION;

BURKITT LYMPHOMA; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, VIRAL; GENE SILENCING; GENETIC VECTORS; HERPESVIRUS 4, HUMAN; HUMANS; VIRAL MATRIX PROTEINS; VIRUS ACTIVATION; VIRUS REPLICATION;

HUMAN HERPESVIRUS 4;

EID: 34248227816     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.82790-0     Document Type: Article

References (35)

1. Allen, M. D., Young, L. S. & Dawson, C. W. (2005). The Epstein-Barr virus-encoded LMP2A and LMP2B proteins promote epithelial cell spreading and motility. J Virol 79, 1789-1802.
2. Babcock, G. J. & Thorley-Lawson, D. A. (2000). Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors. Proc Natl Acad Sci U S A 97, 12250-12255.
3. Babcock, G. J., Hochberg, D. & Thorley-Lawson, A. D. (2000). The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity 13, 497-506.
4. Bernasconi, M., Berger, C., Sigrist, J. A., Bonanomi, A., Sobek, J., Niggli, F. K. & Nadal, D. (2006). Quantitative profiling of house-keeping and Epstein-Barr virus gene transcription in Burkitt lymphoma cell lines using an oligonucleotide microarray. Virol J 3, 43.
5. Caldwell, R. G., Brown, R. C. & Longnecker, R. (2000). Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic mice. J Virol 74, 1101-1113.
6. Daibata, M., Humphreys, R. E., Takada, K. & Sairenji, T. (1990). Activation of latent EBV via anti-IgG-triggered, second messenger pathways in the Burkitt's lymphoma cell line Akata. J Immunol 144, 4788-4793.
7. Fruehling, S. & Longnecker, R. (1997). The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction. Virology 235, 241-251.
8. Fruehling, S., Lee, S. K., Herrold, R., Frech, B., Laux, G., Kremmer, E., Grasser, F. A. & Longnecker, R. (1996). Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction. J Virol 70, 6216-6226.
9. Fukuda, M. & Longnecker, R. (2005). Epstein-Barr virus (EBV) latent membrane protein 2A regulates B-cell receptor-induced apoptosis and EBV reactivation through tyrosine phosphorylation. J Virol 79, 8655-8660.
10. Graham, F. L., Smiley, J., Russell, W. C. & Nairn, R. (1977). Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36, 59-74.
11. Konishi, K., Maruo, S., Kato, H. & Takada, K. (2001). Role of Epstein-Barr virus-encoded latent membrane protein 2A on virus-induced immortalization and virus activation. J Gen Virol 82, 1451-1456.
12. Longnecker, R., Druker, B., Roberts, T. M. & Kieff, E. (1991). An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase. J Virol 65, 3681-3692.
13. Longnecker, R., Miller, C. L., Miao, X. Q., Marchini, A. & Kieff, E. (1992). The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential. J Virol 66, 6461-6469.
14. Lynch, D. T., Zimmerman, J. S. & Rowe, D. T. (2002). Epstein-Barr virus latent membrane protein 2B (LMP2B) co-localizes with LMP2A in perinuclear regions in transiently transfected cells. J Gen Virol 83, 1025-1035.
15. Mancao, C., Altmann, M., Jungnickel, B. & Hammerschmidt, W. (2005). Rescue of 'crippled' germinal center B cells from apoptosis by Epstein-Barr virus. Blood 106, 4339-4344.
16. Matskova, L., Ernberg, I., Pawson, T. & Winberg, G. (2001). C-terminal domain of the Epstein-Barr virus LMP2A membrane protein contains a clustering signal. J Virol 75, 10941-10949.
17. Merchant, M., Caldwell, R. G. & Longnecker, R. (2000). The LMP2A ITAM is essential for providing B cells with development and survival signals in vivo. J Virol 74, 9115-9124.
18. Miller, C. L., Lee, J. H., Kieff, E., Burkhardt, A. L., Bolen, J. B. & Longnecker, R. (1994a). Epstein-Barr virus protein LMP2A regulates reactivation from latency by negatively regulating tyrosine kinases involved in sIg-mediated signal transduction. Infect Agents Dis 3, 128-136.
19. Miller, C. L., Lee, J. H., Kieff, E. & Longnecker, R. (1994b). An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking. Proc Natl Acad Sci U S A 91, 772-776.
20. Miller, C. L., Burkhardt, A. L., Lee, J. H., Stealey, B., Longnecker, R., Bolen, J. B. & Kieff, E. (1995). Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity 2, 155-166.
21. Murray, P. G. & Young, L. S. (2002). The role of the Epstein-Barr virus in human disease. Front Biosci 7, d519-d540.
22. Portis, T., Cooper, L., Dennis, P. & Longnecker, R. (2002). The LMP2A signalosome - a therapeutic target for Epstein-Barr virus latency and associated disease. Front Biosci 7, d414-d426.
23. Portis, T., Ikeda, M. & Longnecker, R. (2004). Epstein-Barr virus LMP2A: regulating cellular ubiquitination processes for maintenance of viral latency? Trends Immunol 25, 422-426.
24. Rickinson, A. B. & Kieff, E. (2001). Epstein-Barr Virus. In Fields Virology, 4th edn, pp. 2575-2627. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott Williams & Wilkins.
25. Rovedo, M. & Longnecker, R. (2007). Epstein Barr virus latent membrane protein 2B (LMP2B) modulates LMP2A activity. J Virol 81, 84-94.
26. Rowe, D. T. (1999). Epstein-Barr virus immortalization and latency. Front Biosci 4, D346-D371.
27. Sample, J., Liebowitz, D. & Kieff, E. (1989). Two related Epstein-Barr virus membrane proteins are encoded by separate genes. J Virol 63, 933-937.
28. Schaefer, B. C., Mitchell, T. C., Kappler, J. W. & Marrack, P. (2001). A novel family of retroviral vectors for the rapid production of complex stable cell lines. Anal Biochem 297, 86-93.
29. Speck, P., Kline, K. A., Cheresh, P. & Longnecker, R. (1999). Epstein-Barr virus lacking latent membrane protein 2 immortalizes B cells with efficiency indistinguishable from that of wild-type virus. J Gen Virol 80, 2193-2203.
30. Stewart, S., Dawson, C. W., Takada, K., Curnow, J., Moody, C. A., Sixbey, J. W. & Young, L. S. (2004). Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway. Proc Natl Acad Sci U S A 101, 15730-15735.
31. Swart, R., Ruf, I. K., Sample, J. & Longnecker, R. (2000). Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-kinase/Akt pathway. J Virol 74, 10838-10845.
32. Takada, K. (1984). Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines. Int J Cancer 33, 27-32.
33. Tao, Q., Robertson, K. D., Manns, A., Hildesheim, A. & Ambinder, R. F. (1998). Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: molecular analysis of primary tumor tissue. Blood 91, 1373-1381.
34. Ventura, A., Meissner, A., Dillon, C. P., McManus, M., Sharp, P. A., Van Parijs, L., Jaenisch, R. & Jacks, T. (2004). Cre-lox-regulated conditional RNA interference from transgenes. Proc Natl Acad Sci U S A 101, 10380-10385.
35. Young, L. S. & Murray, P. G. (2003). Epstein-Barr virus and oncogenesis: from latent genes to tumours. Oncogene 22, 5108-5121.